Henry Schein, Inc. (NASDAQ:HSIC) Stock Rating Upgraded by Northcoast Research
Northcoast Research upgraded shares of Henry Schein, Inc. (NASDAQ:HSIC) from a neutral rating to a buy rating in a research note released on Monday morning, MarketBeat reports. The firm currently has $218.00 target price on the stock. Northcoast Research also issued estimates for Henry Schein’s Q2 2017 earnings at $1.77 EPS, Q3 2017 earnings at $1.85 EPS, Q4 2017 earnings at $1.99 EPS, FY2017 earnings at $7.38 EPS, Q1 2018 earnings at $2.01 EPS, Q2 2018 earnings at $2.00 EPS and FY2018 earnings at $8.22 EPS.
Other research analysts have also issued research reports about the stock. Jefferies Group LLC reiterated a hold rating and set a $177.00 price objective on shares of Henry Schein in a research note on Friday, July 21st. Zacks Investment Research upgraded shares of Henry Schein from a hold rating to a buy rating and set a $190.00 price objective for the company in a research note on Tuesday, April 25th. Stifel Nicolaus reiterated a hold rating on shares of Henry Schein in a research note on Thursday, July 6th. Barrington Research boosted their price objective on shares of Henry Schein from $196.00 to $198.00 and gave the stock an outperform rating in a research note on Wednesday, May 10th. Finally, BidaskClub lowered shares of Henry Schein from a hold rating to a sell rating in a research note on Wednesday, August 2nd. One research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating to the company. The stock presently has a consensus rating of Hold and a consensus target price of $185.56.
Henry Schein (NASDAQ HSIC) traded down 3.7518% during midday trading on Monday, hitting $176.8945. 745,466 shares of the stock were exchanged. The company has a market cap of $14.03 billion, a PE ratio of 26.8837 and a beta of 1.09. The firm’s 50 day moving average price is $183.44 and its 200 day moving average price is $174.47. Henry Schein has a 12 month low of $146.23 and a 12 month high of $186.99.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, August 8th. The company reported $1.75 EPS for the quarter, topping the consensus estimate of $1.74 by $0.01. The firm had revenue of $3.06 billion during the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a net margin of 4.53% and a return on equity of 19.74%. Henry Schein’s revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.64 EPS. On average, equities research analysts forecast that Henry Schein will post $7.29 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This story was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this story can be viewed at https://www.dailypolitical.com/2017/08/08/henry-schein-inc-nasdaqhsic-stock-rating-upgraded-by-northcoast-research.html.
In other news, EVP Gerald A. Benjamin sold 12,578 shares of the company’s stock in a transaction on Thursday, May 11th. The shares were sold at an average price of $175.10, for a total value of $2,202,407.80. Following the sale, the executive vice president now directly owns 44,061 shares of the company’s stock, valued at approximately $7,715,081.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.27% of the stock is owned by corporate insiders.
Hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its stake in Henry Schein by 1.7% in the first quarter. Vanguard Group Inc. now owns 7,849,455 shares of the company’s stock valued at $1,334,173,000 after buying an additional 127,660 shares during the period. BlackRock Inc. increased its stake in Henry Schein by 2,999.6% in the first quarter. BlackRock Inc. now owns 5,595,279 shares of the company’s stock valued at $951,028,000 after buying an additional 5,414,761 shares during the period. State Street Corp increased its stake in Henry Schein by 1.3% in the first quarter. State Street Corp now owns 3,675,674 shares of the company’s stock valued at $624,760,000 after buying an additional 48,469 shares during the period. Mackenzie Financial Corp increased its stake in Henry Schein by 4.7% in the first quarter. Mackenzie Financial Corp now owns 1,728,230 shares of the company’s stock valued at $293,747,000 after buying an additional 76,794 shares during the period. Finally, JPMorgan Chase & Co. increased its stake in Henry Schein by 12.4% in the first quarter. JPMorgan Chase & Co. now owns 1,515,861 shares of the company’s stock valued at $257,650,000 after buying an additional 167,213 shares during the period. 90.87% of the stock is currently owned by institutional investors and hedge funds.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.